跳至主要内容
临床试验/NL-OMON39503
NL-OMON39503已完成不适用

Simplified monitoring of post-treatment CIN2/3 women by molecular testing for hrHPV and methylation markers - Simplified monitoring post-treatment

Vrije Universiteit Medisch Centrum0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -A histological confirmed CIN2/3 lesion that will be treated by cone biopsy or colposcopic guided LLETZ.
  • - Written informed consent prior to enrolment.
  • - Sufficient knowledge of the Dutch language.
  • - A minimum age of 18 years.
  • -The intention to comply with the requirements of the protocol.

排除标准

  • -The subject is pregnant (or has been in the last three months)
  • -The subject has received prophylactic (or therapeutic) HPV- vaccination.
  • -The subject has a diagnosis of carcinoma in cone biopsy or colposcopic guided LLETZ

研究者

相似试验

Simplified monitoring of post-treatment CIN2/3 women... | 临床试验